BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«PTGS2

Below is an extended PTGS2 publications listing. Click here to return to the gene page.

Gene Information from Publications

Publication Link Summary of findings
18029351 COX-2 has the ability to enhance iNOS-induced cPLA(2)alpha S-nitrosylation and maximal PG synthesis is achieved by the synergistic interaction among iNOS, cPLA(2)alpha, and COX-2
18000398 Tumor COX-2 expression portends a poor prognosis for patients with resected adenocarcinoma of the pancreas, particularly in tumors > or =3 cm.
18214026 Observational study of gene-disease association. (HuGE Navigator)
18234542 Observational study of gene-disease association. (HuGE Navigator)
18287876 Observational study of gene-disease association. (HuGE Navigator)
18311113 Observational study of gene-disease association. (HuGE Navigator)
18330937 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
18349295 Observational study of gene-disease association. (HuGE Navigator)
18350611 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
18172254 COX-2 overexpression in glottic cancer was associated with increased overall mortality and an increased risk of second primary cancers in head and neck cancer patients during the early follow-up period
17553653 COX-2 overexpression was significantly correlated with depth of invasion, tumor stage and survival in esophageal squamous cell carcinoma.
17350020 We have found the COX-2 G-765C polymorphism to be a risk factor for incident stroke in African-Americans
16760271 COX-2 may play a key role in the development and progression of gastric adenoma
17962194 PAR2 up-regulates cyclooxygenase-2 expression via an ERK1/2-mediated activation.
18173398 The results of the study suggest that the -765G to C polymorphism of the COX-2 gene is associated with a decreased risk for periodontitis in Taiwanese, especially in AgP. However, the biological meaning needs further investigation.
18097055 HIV-1 Tat was able to induce COX-2 and PGE2 synthesis in astrocytic cells through an NFAT/AP-1-dependent mechanism.
18214026 results suggest that the polymorphisms examined in COX1 and COX2 do not affect the risk of gastric cancer
18190720 COX-2 may up-regulate VEGF-C expression and thus promote lymph node metastasis via lymphangiogenesis pathway in human breast cancer.
11309440 Observational study of gene-disease association. (HuGE Navigator)
12164325 Observational study of genotype prevalence. (HuGE Navigator)
12377741 Observational study of gene-disease association. (HuGE Navigator)
12433707 Observational study of gene-disease association. (HuGE Navigator)
12718655 Observational study of gene-disease association. (HuGE Navigator)
12920574 Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)
14604894 Observational study of gene-disease association. (HuGE Navigator)
14749922 Observational study of gene-disease association. (HuGE Navigator)
14754878 Observational study of gene-disease association. (HuGE Navigator)
15138244 Observational study of gene-disease association. (HuGE Navigator)
15150618 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
15167446 Observational study of gene-disease association. (HuGE Navigator)
15173859 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
15544595 Observational study of gene-disease association. (HuGE Navigator)
15550453 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
15596291 Observational study of gene-disease association. (HuGE Navigator)
15767339 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
15777967 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
15882925 Observational study of gene-disease association. (HuGE Navigator)
15930344 Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)
16024651 Observational study of gene-disease association. (HuGE Navigator)
16083713 Observational study of gene-disease association. (HuGE Navigator)
16150050 Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
16181776 Observational study of gene-disease association. (HuGE Navigator)
16205694 Observational study of gene-disease association. (HuGE Navigator)
16273614 Observational study of gene-disease association. (HuGE Navigator)
16309832 Observational study of gene-disease association. (HuGE Navigator)
16344721 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
16361272 Observational study of gene-disease association. (HuGE Navigator)
16407418 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
16453284 Observational study of gene-disease association. (HuGE Navigator)
16458279 Observational study of gene-disease association. (HuGE Navigator)
16479190 Observational study of gene-disease association. (HuGE Navigator)
16489098 Observational study of gene-disease association. (HuGE Navigator)
18006935 Observational study of gene-disease association. (HuGE Navigator)
16506214 Observational study of gene-disease association. (HuGE Navigator)
16542464 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
16678543 Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
16702043 Observational study of gene-disease association. (HuGE Navigator)
16733888 Observational study of gene-disease association. (HuGE Navigator)
16762620 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
16775170 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
16788380 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
16821264 Observational study of gene-disease association. (HuGE Navigator)
16840740 Observational study of gene-disease association. (HuGE Navigator)
16871410 Observational study of gene-disease association. (HuGE Navigator)
16879213 Observational study of gene-disease association. (HuGE Navigator)
16905570 Observational study of gene-disease association. (HuGE Navigator)
16959787 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
17006983 Observational study of gene-disease association. (HuGE Navigator)
17058024 Observational study of gene-disease association, gene-gene interaction, and genetic testing. (HuGE Navigator)
17066444 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
17151091 Observational study of gene-disease association. (HuGE Navigator)
17171651 Observational study of gene-disease association. (HuGE Navigator)
17178263 Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
17181859 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
17202846 Observational study of gene-disease association. (HuGE Navigator)
17214885 Observational study of gene-disease association. (HuGE Navigator)
17234302 Observational study of gene-disease association. (HuGE Navigator)
17307204 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
17350020 Observational study of gene-disease association. (HuGE Navigator)
17355643 Observational study of genotype prevalence. (HuGE Navigator)
17356794 Observational study of gene-disease association. (HuGE Navigator)
17373929 Observational study of genotype prevalence. (HuGE Navigator)
17404026 Observational study of gene-disease association. (HuGE Navigator)
17460548 Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)
17479405 Observational study of gene-disease association. (HuGE Navigator)
17495879 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
17573729 Observational study of gene-disease association. (HuGE Navigator)
17578436 Observational study of gene-disease association. (HuGE Navigator)
17581270 Observational study of gene-disease association. (HuGE Navigator)
17581413 Observational study of gene-disease association. (HuGE Navigator)
17609663 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
17631383 Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)
17640058 Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
17702963 Observational study of gene-disease association. (HuGE Navigator)
17851225 Observational study of gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
17924829 Observational study of gene-gene interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
17968676 Observational study of gene-disease association. (HuGE Navigator)
17999989 Observational study of gene-disease association. (HuGE Navigator)
18038187 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
18085997 Observational study of genetic testing. (HuGE Navigator)
18164040 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
18167131 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
18173398 Observational study of gene-disease association. (HuGE Navigator)
16489533 Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
18064329 Alternative splicing of platelet COX2 mRNA after coronary bypass grafting may be a posttranscriptional mechanism opposing transactivation of COX-2. Prevents COX-2-dependent thromboxane synthesis in the platelet, increasing the likelihood of thrombosis.
17604853 the transcriptional activity of the COX-2 gene in colorectal cancer cells and the identification of regulatory promoter elements
17936921 transactivation of the COX-2 promoter and MAPK pathway by cholecystokinin-2/gastrin receptor
18156149 LPS-activated monocytes suppress T cell immune responses and induce FOXP3 expression in resting CD4+CD25- T cells through a COX-2-PGE2-dependent mechanism.
17455223 PRKCD-mediated CREB activation regulates ghrelin-induced COX-2 expression and dinoprostone production in colonic epithelial cells.
17977913 COX-1 and COX-2 are constitutively expressed at relatively high levels in human patellar tendon and are likely targets of COX-inhibiting drugs at rest and after physical activity.
17640750 These results demonstrate for the first time that PLD1 and PLD2 isozymes enhance cobalt chlorde-induced COX-2 expression through differential signaling pathways in astroglioma cells.
18199541 COX-2 expression is decreased in breast cancer cell lines and cancer specimens as compared with normal mammary epithelial cells.
18027256 There was a statistically significant correlation between COX-2 immunoreactivity and the cytoplasmic HuR expression level in laryngeal squamous cell carcinoma.
18032824 Stromal myofibroblasts surrounding colon adenocarcinomas are an important source of VEGF and COX-2 production.
18097584 we analyzed the signal transduction and COX-2 expression in endometrial cancer cells
18212353 upon stimulation with the same upstream signals, different downstream intracellular pathways regulate PTGS2 and PGDH mRNA expression
18181047 Osteopontin, cyclooxygenase-2 and vascular endothelial growth factor synergically promote angiogenesis and metastasis in gastric cancer.
17876541 CDX2 inhibits transcription of Cox-2 by interfering with the binding of NF-kappaB on the NF-kappaB binding site.
18064740 Methylation may predict biochemical recurrence in prostate cancer patients undergoing radical prostatectomy. in prostate cancer patients undergoing radical prostatectomy
17495879 Genetic variation in PTGS1 and PTGS2 may be important risk factors for the development of cardiovascular disease events.
17693978 COX-2 and iNOS was significantly higher in chronic fatigue syndrome patients than in normal controls.
17823287 AhR activation and COX-2 overexpression likely represent a mechanism of resistance to apoptosis in lymphoma cell lines that might be relevant for the development of lymphoma in vivo.
17982644 COX-2 mRNA and proteins were significantly reduced by up to 80% on day 2 after COX-2 siRNA transfection to the gastric cancer cell line.
18094075 COX-2 expression is dependent on calcium and protein kinase C
17955050 The experiments presented here demonstrated that COX-2 transfection of a TGF-beta-sensitive cell line abrogates the growth inhibitory effects of TGF-beta.
17991613 LTD(4) promotes formation of an atherosclerosis-protective and anti-thrombotic eicosanoid by markedly up-regulating EC cyclooxygenase-2 (COX-2).
17916229 In healthy volunteers, COX-2 inhibition inhibited systemic PGE2/PGI2 synthesis and stimulated TXB2 release from activated platelets.
17581270 COX-2 CA-haplotype is a risk factor for development of esophageal adenocarcinoma.
17303142 human aortic smooth muscle cells prostacyclin 2 synthase(PGIS) gene transfer reduced peroxisome proliferator-activated receptor delta(PPAR-delta) expression and inhibited neointimal formation after balloon injury
17643350 Data show that the Ca2+-dependent type IV cytosolic phospholipase A2 (cPLA2) is pivotally involved in the COX-2-mediated generation of PGE2 in response to a calcium ionophore.
17982107 Jak2 ordinarily dampens and limits the duration of the PGHS-2 induction by IL-1beta.
17244951 Our present study demonstrated a significant overexpression of COX-2 at the mRNA and protein level in the Barrett's epithelium
17711445 The switching of linoleic acid metabolism by reversal of the expression of 15LOX-1 and COX-2 is associated with acquisition of malignant potential in colonic neoplasia.
17968936 microparticles up-regulate the production of PGE(2) in synovial fibroblasts by inducing COX-2 and mPGES-1 in rheumatoid arthritis
17222248 Increasing COX-2 expression in Barrett's metaplasia is significantly associated with a change in the local inflammatory reaction, but not during further progression through dysplasia to cancer
17927697 We report that Bordetella persussis ACT ( adenylate cyclase toxin) induces COX-2 in HEK293T cells expressing Mac-1.
17961495 Together, our results demonstrated that COX-2 expression could be induced by vanadium pentoxide in NFAT-dependent way and played an anti-apoptotic role in Beas-2B cells.
17855346 We report that arachidonic acid lipid hydroperoxide metabolites of 5-, 12-, 15-lipoxygenase-1, and cyclooxygenase-2 oxidize the 2-Cys-peroxiredoxins 1, 2, and 3 to their sulfinic and sulfonic forms.
17881124 Three classes of inflammatory repressors act synergistically in modulating PAF-induced up-regulation of COX-2, TNFalpha, and PGE(2) by quenching oxidative stress or inflammatory signaling, resulting in increased HN cell survival.
17651852 These data suggest that the COX-2-dependent pathway appears to assist TMT-induced degeneration of CA1 pyramidal cells but not CA3 pyramidal cells in a corticosterone-independent manner.
17970040 These results suggested that tumor-produced COX-2, which was associated with inhibiting apoptosis and promoting angiogenesis, provided additional prognostic information in endometrial cancer patients.
17673564 COX-2 is expressed and enzymatically active in myocytes of skeletal muscles and hearts of humans.
17560572 Results indicate that COX-2 is highly up-regulated during both normal and stress-induced fibroblast senescence and contributes to the establishment of the senescent characteristics.
17627037 Results indicate that gp120 induces COX-2 transcription through NF-kappaB activation in astrocytoma cells.
18006811 Rho-GDI beta has two roles: one that suppresses tumor progression by inhibiting migration and the other that stimulates it by enhancing Cox-2 expression
17707579 High concentrations of specific COX2 inhibitors inhibited proliferation of esophageal tumor cell lines.
16912190 Discoidin domain receptor family member 1-mediated Cox-2 induction is NF-kappaB dependent in breast cancer.
17671679 VEGF, MMP2, 7 and 9, and COX-2 expression is related to progression of advanced uterine cervical cancer in young women
17671709 High frequency of expression in central nervous system lymphomas may be associated with tumorigenesis may lead to futural therapeutic trials.
17640058 polymorphisms are unlikely to influence colorectal adenoma recurrence and cannot be used to identify individuals who derive benefit from aspirin interventio
16912160 Reintroduction of wild-type LKB1 into cells induced down-regulation of PEA3 resulted in reduced cyclooxygenase-2 RNA and protein expression.
17657731 This study demonstrates a strong positive relationship between COX-2 and aromatase mRNA expression, and lends further support to the hypothesis that COX-2 is an upregulator of aromatase in breast tissue
17018629 Aldose reductase is an obligatory mediator of growth factor-induced up-regulation of COX-2.
17952860 Breast cancer progression is associated with the accumulation of glucocorticoid receptor in the cytoplasm of tumoral cells and the decrease of COX-2 expression.
17868457 these results demonstrate that vGPCR induces expression of COX-2 and PGE2 that may mediate the paracrine effects of this key viral protein in KS pathogenesis.
17392515 Data show that regulation of HuR via protein kinase C alpha-dependent phosphorylation emphasizes the importance of posttranslational modification for stimulus-dependent HuR shuttling.
17578436 COX-2 common variants -765G-->C and -1195A-->G appear to be associated with risk of nonmelanoma skin cancer, although in different ways in the squamous cell skin carcinoma and basal cell carcinoma subgroups
17683115 mechanism of COX-2 protein induction expression in PMN is substantially different from that operative in mononuclear phagocytes, which is highly dependent on transcriptional regulation
16979925 The results demonstrated statistically significant increased oral mucosal staining for NF-kappaB and COX-2 following cytotoxic chemotherapy and provide further support for the role of NF-kappaB and COX-2 in the pathogenesis of mucositis.
16979927 This study failed to demonstrate any prognostic significance of COX-2 expression alone or co-expression with HIF-1alpha or VEGF in advanced NPC.
17868881 COX-2 probably mediates inflammatory reaction in myocardial infarction. COX-1 and COX-2 are associated with the healing processes and scar formation after myocardial infarction.
17635918 GS-HCl inhibits COX-2 activity by preventing COX-2 co-translational N-glycosylation and by facilitating COX-2 protein turnover during translation in a proteasome-dependent manner
17581812 low density lipoprotein (LDL) that had been denatured by freeze-thawing or oxidized LDL might be involved in the COX-2 induction
17650224 The expression of cyclooxygenase-2 COX2) was significantly higher in esophogeal squamous cell neoplasm than in non-tumorous tissue.
17550984 Signaling pathways involved in PTGS2 induction by hepatocyte growth factor in non-small-cell lung carcinoma are reported.
17562850 dexamethasone reduces vasoconstriction to electrical field stimulation in rat mesenteric arteries from spontaneously hypertensive rats by decreasing COX-2 expression, decreasing the smooth muscle TXA(2) release induced by alpha-adrenoceptor activation
17724132 Metabolism of endocannabinoids by the endothelial cell COX-2 coupled to the prostacyclin (PGI(2)) synthase activates the nuclear receptor peroxisomal proliferator-activated receptor delta, which negatively regulates the expression of tissue factor.
17457030 results suggest that COX-2 expression may be differentially regulated among subdivisions of the hippocampus and that elevated COX-2 expression in the CA1 of Alzheimer's disease (AD) brains may be associated with AD pathology and thus cognitive dysfunction
17308999 Patients with tumor lacking cyclooxygenase-2 expression before chemoradiotherapy are more likely to demonstrate good response to treatment.
17609663 Our findings suggest that variation in COX2 is associated with prostate cancer risk.
17710160 Cytoplasmic beta-catenin is associated with COX-2 overexpression, supporting the role of cytoplasmic beta-catenin in stabilizing PTGS2 (COX-2) mRNA.
17572069 E-prostanoid receptors 2-4, but not 1, transactivated the epidermal growth factor receptor, through tumor necrosis factor-alpha converting enzyme.
17525067 participates in placentation through EVT invasion by up-regulating PGE2 production and PGE2 receptor expression in first trimester extravillous trophoblasts
17395887 Results show for the first time acetylation via selective degradation of histone deacetylase 1, and that recruitment of histone acetyltransferase plays an important role in diesel exhaust particulate matter-induced expression of the cyclooxygenase-2 gene.
17542993 COX-2 is highly expressed in lobular in situ neoplasia, supporting a role for this protein in the early stage of breast carcinogenesis, representing the rationale for using COX-2 selective inhibitors in the earliest stages of breast cancer.
17624243 Expression might be addressed as a new prognostic tool in the clinical management of oral squamous cell carcinoma.
17581403 Results suggest that the cytoplasmic overexpression of HuR is associated with uterine cervical carcinomas with aggressive clinicopathologic features and that HuR might contribute to the stabilization of COX-2 mRNA in some uterine cervical carcinomas.
17581404 Data support that there are significant differences between EGFR and COX-2 expressions in the 3 different histogenetic types of cervical cancer.
17581413 A fetal polymorphism in the COX-2 gene influences the occurrence of placental malperfusion and ischemia, which may be of sufficient severity to promote or allow the development of intrauterine growth retardation.
17611676 Results show co-expression of cyclooxygenase-2 and prostaglandin E2 receptors EP1, 2 and 4 in non-small cell lung cancer cells concomitant with the synthesis of PGE2.
17573729 PTGS2.8473 polymorphism is associated with asthma, atopy and lung function but not plasma IgE in Chinese children.
17678966 mechanisms leading to microglial COX-2 expression as well as its potential implication in prion disease pathogenesis remain to be established--REVIEW
17681165 Slow transit constipation is due to abnormal levels of COX1/2 and prostaglandins, probably caused by overexpression of progesterone receptors in colonic smooth muscle.
17624083 COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.
17631744 YKL-40 release by intervertebral disc culture may better clarify its role in the pathophysiology of discal degeneration and inflammation and its relationships with COX-2 and NO in disc tissue culture.
17011110 Human labor is associated with increased expression of COX-2 in the myometrium.
17645803 The major subtypes of renal epithelial neoplasms display differential aberrant CDH1, PTGS2, and RASSF1A promoter methylation levels. This gene panel might contribute to a more accurate discrimination among common renal tumors.
11981837 COX-2 appears to be constitutively and selectively present in medullary epithelial cells of the human thymus.
12124799 Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
15013358 COX-2 mrna expression in peripheral blood monocytes showed marginal increase in eary postoperative period.
15328521 Cox-2 expression is highly variable in Dukes' C colorectal tumors.
15383564 In situ processing of COX-2-overexpressing glioma by tumor-infiltrating dendritic cells induces a tolerogenic T cell response by means of generating a CD4+ T regulatory type 1 (Tr1) response.
15978332 COX-2 upregulation showed to be a late event and in a multivariate analysis it was associated independently with a reduced survival after surgery compared with low COX-2 expressed esophageal tumors
16243808 High COX-2 is an independent prognostic factor in gastric cancer.
11844819 increased expression associated with chemotherapy resistance and poor survival in cervical cancer
12050157 expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells
12050227 cyclooxygenase gene expression in human preimplantation embryos.
11959891 Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells
15756444 COX-2 has a role in response of esophageal squamous cell carcinoma to chemoradiotherapy
15812311 under specific conditions of cellular stress, a common variation in cyclooxygenase-2 promoter structure may enhance cyclooxygenase-2 transcription, and this may contribute to the proliferation of an inflammatory response in brain cells
11880271 in intestinal myofibroblasts, IL-1-mediated induction of COX-2 expression is a complex process that requires input from multiple signaling pathways.
11972392 Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu are expressed in ovarian cancer.
14517215 COX-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, EP2 receptor, and EP4 receptor
15968728 Augmented tumor neovascularization induced by VEGF may be one of the several effects of COX-2 responsible for poor prognosis of human gallbladder carcinoma
16497971 a selective induction of cox-2 in multiple myeloma cells containing RAS mutations, results in heightened binding to extracellular matrix protein and chemotherapeutic drug resistance
17006983 The -765G > C COX-2 polymorphism should be considered as another susceptibility marker for gastric adenocarcinoma development in patients with atrophy or intestinal metaplasia.
17113084 COX-2 turnover appears to depend upon glycosylation of the 72kDa glycoform.
17218407 Stretch of the amnion, on onset of labor, may contribute to increased expression of COX-2.
12865795 potential involvement transplant rejection
14726416 TXA2 produced by COX-2 plays an important role in megakaryocytopoiesis.
15063780 We propose that a component of the cytokine-induced Cox-2 mRNA stabilization pathway is sensitive to acetylation.
12397176 mediates the proliferative action of mast-cell tryptase: possible relevance to human fibrotic disorders
14616542 Expression of Cox-2 is elevated in gastric adenocarcinomas, which correlates with several clinicopathological parameters, including depth of invasion and lymph node metastasis.
15221958 Fibronectin stimulates human lung carcinoma cell proliferation and diminishes apoptosis by inducing COX-2 gene expression and PGE2 biosynthesis.
15222024 iNOS and COX-2 may play a synergistic role in the pathogenesis of gastric MALT lymphoma.
15222037 half of the cases expressed iNOS and COX-2, but these two enzymes do not seem to be the key step in angiogenesis or carcinogenesis of pancreatic adenocarcinomas.
15272284 COX-2 expression was observed in 30 of the 68 tumor samples (44%).
15319438 cyclooxygenase-2 expression is stimulated by endoplasmic reticulum stress through activation of NF-kappaB and pp38 mitogen-activated protein kinase
16110762 there is higher stromal COX-2 mRNA expression compared to that within the epithelium for colorectal adenomas and carcinomas
16111807 cyclooxygenase-2 elevation is related to lymph node metastasis in adenocarcinoma of uterine cervix
16203768 histamine exerts both a proproliferative and a proangiogenic effect via H2/H4 receptor activation, mediated by increasing COX-2-related PGE2 production in COX-2-expressing colon cancer cells
12349897 NFkappaB transcription factor is a key regulator of COX-2 expression in TNF-alpha-induced PGE2 production
12391278 Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertension.
12767532 Orthotopic implantation of a colon cancer xenograft induces high expression of cyclooxygenase-2.COX-2 plays an important role in organ-specific liver metastasis of colon cancer.
14729623 Expression of cyclooxygenase (COX)-2 is related to poor prognosis in ovarian carcinoma.
16875891 Study suggests that COX-2 enzyme is important regulator of bone mineral density and bone strength.
17507659 Identification of PSF, p54(nrb), PTB, and U1A as proteins specifically bound to the COX-2 polyadenylation signal upstream sequence elements .
12444028 Induction of COX-2 may contribute to the inhibition of hypoxia-induced pulmonary vascular remodeling.
12498388 The COX-2 expression in PC-3 High Invasive cells was approximately 3-fold higher than in PC-3 Low Invasive cells while the COX-1 expression was similar in both cell sublines.
14501677 Over expression of COX-2 in reflux nephropathy suggests that COX-2 may be involved in the pathogenesis of tubulointerstitial damage associated with severe reflux nephropathy.
15692221 Renal medullary oxygenation is improved by water diuresis in normal young women in a way that is blocked by a selective inhibitor of COX-2 as well as non-selective cyclooxygenase inhibitors.
15800927 results suggest E1A-F is overexpressed in early stages of human CRC development and may be an important factor in the overexpression of COX-2 and MMP-7
15929167 Helicobacter pylori infection transactivates COX-2 promoter activity and increases the binding of NF-kappaB to this promoter.
15929174 The demethylation of 5' CpG island of gene is necessary for COX-2 expression in human gastric cancer.
15994313 Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2
16157291 Expression in kidney is a useful maker for tumorigenesis of the renal call carcinoma in vivo.
16612568 Data show that substance P stimulates production of prostaglandin E2 and receptor activator of nuclear factor- B ligand, and promotes bone resorption.
17265445 correlation between COX-2 and polo-like kinase-1 in a malignant prostate tumor
12401798 PGE(2) production via a COX-2-catalyzed pathway plays a critical role in HIF-1alpha regulation by hypoxia; COX-2 inhibitors can prevent hypoxic induction of HIF-mediated gene transcription
12777984 Cox-2 was established as a specific tumour marker for melanoma of potential interest for targeted therapeutics.
14724276 COX-2-mediated cross-linking may inhibit Abeta catabolism and possibly generate toxic intracellular forms of oligomeric Abeta
14966191 costimulatory effect of DEP & LPS led to enhanced production of COX-2 protein and to increased release of prostaglandin E(2); the effect was specific
17264103 Analysis of gene expression demonstrated a significant elevation in expression of COX-1 and COX-2 mRNA in endometrium obtained from women with heavy MBL (menstrual blood loss) when compared with endometrium obtained from women with normal MBL.
17459764 n-3 and n-6 polyunsaturated fatty acids increase PPARG activity is necessary for cyclooxygenase-2 induction in a human keratinocyte cell line.
17536311 COX-2 is expressed at high levels in high grade osteosarcomas
15550400 COX-2-positive prostate cancer cells can have impaired p53 function even in the presence of wild-type p53 and that p53 activity can be restored in these cells via inhibition of COX-2 activity.
16203985 The COX-2-related pathway, which is essential in mediating cellular inflammatory response, is the critical signaling link for the bystander phenomenon.
16273614 Allele 5209G was weakly associated with Crohn's disease (odds ratio (OR) 1.63, 95% confidence interval (CI) 1.03-2.57), and allele 8473T with ulcerative colitis (OR 1.50, 95%CI 1.00-2.27).
16481301 Logistic regression analysis showed p53 and COX-2 as dependent predictors in pancreatic carcinogenesis, and a reciprocal relationship to neoplastic progression between p53 and COX-2.
16675095 Vaginal administration of the nitric oxide donor isosorbide mononitrate (IMN) induces increased cervical expression of COX-2;this pathway may act in cervical ripening at term.
16782382 study demonstrates that when cytomegalovirus replicates in retinal pigment epithelial cells, COX-2 induction augments virus replication via the PGE pathway
16921134 Decreased PGI2S protein and mRNA in the lungs from patients with emphysema.
17095859 The first evidence of the presence of COX-2 in mature neutrophils in bone marrow. Its expression varied with stage of differentiation. It may have a role in residual hematopoiesis in myelodysplastic marrow.
17105783 COX-2 expression and mPGES-1 expression are co-ordinately up-regulated in lower segment myometrium with term labour.
17341442 These data demonstrate that IGF-I induces COX-2 expression in human ovarian cancer cells, which is mediated by three parallel signaling cascades--PI3K, MAPK, and PKC pathways that differentially regulate COX-2 expression.
17413988 In this test set, cyclooxygenase 2 and Caspase 3 seem to be immunohistochemical markers with prognostic significance for vulva cancer.
17570496 data demonstrated that chronic inflammation appeared to play roles in induction of CCAAT/enhancer-binding protein beta expression in prostate epithelium which was associated with increased Cyclooxygenase-2 expression and androgen receptor downregulation
12533667 The pathway of this enzyme is potentially involved in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer
12875991 Data describe the correlation between inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 activities and p53 gene status in head and neck squamous cell carcinomas in vivo and in vitro.
14630807 p300 is the predominant coactivator that is essential for COX-2 transcriptional activation by proinflammatory mediators.
14871981 COX-2 and mPGES-1 are overexpressed in squamous cell carcinoma of the penis
15478052 Gene expression regulation plays a role in prognosis of ovarian carcinoma.
11897504 the effects of several paracrine and/or autocrine signaling pathways in the regulation of expression of aromatase, COX-1, and COX-2 in breast cells has identified complex relationships
15950941 Altogether our findings revealed that IL-20 is a negative modulator of COX-2/PGE(2) and inhibits angiogenesis.
16393343 EP1 receptor level increase in sensory neurones, and macrophage infiltration, appears to precede increased Cox-2 expression by macrophages in nerve injuries
11948128 In advanced gallbladder carcinoma, enhanced expression of cyclooxygenase-2 is observed in the adjacent stroma.
12720297 COX-1 and COX-2 protein expression levels were determined in sets of tumor and normal colon tissue
15000150 COX-2 has a role in colorectal tumorigenesis [review]
15704107 COX-2 expression in both cancer cells and stromal cells within the lung cancer microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF in lung cancer.
15334675 COX-2 expression induced by H pylori infection is a relatively early event during carcinogenesis in the stomach.
15869467 The generation and antifungal activity of hydroxyeicosanoids from 3-HETE by COX-2 are reported.
16323955 functional and physiological significance of COX-2 in the placenta and in fetal development.
12881220 VEGF is one of the principal factors produced by hypoxic myocytes that is responsible for the induction of endothelial cell COX-2 expression.
16820889 COX-2 is downregulated by PC-SPES via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells
16930602 results suggest that COX-1 and COX-2 activities are decreased in the placental tissue of women with pre-eclampsia, probably by oxidative stress
16950767 Lipopolysaccharide-induced up-regulation of COX-2 depends on the activity of the Mg(+2)-dependent phosphatidic acid phosphohydrolase 1 (PAP-1)
17050069 Results suggest that irrespective of the underlying disease, lung injury that causes extensive fibrosis induces wide expression of COX-2 in the regenerating metaplastic epithelium.
12748469 COX-2 expression is significantly more common in endometrial adenocarcinoma and ovarian serous cystadenocarcinoma, but not in cervical squamous carcinoma, compared with normal tissue.
14566822 NO can be associated with carcinogenesis through the upregulation of COX-2
15754118 High cyclooxygenase-2 expression is associated with breast cancer
15654517 gene expression regulation in Lyme disease
15720413 Results showed a stepwise increase in the expression of COX-2 as mucosal damage progressed from normal to gastritis to gastric ulcer.
15831295 Regulation of COX-2 may alter peritoneal healing and may provide the opportunity to reduce postoperative adhesion development.
16473553 Expression of cyclooxygenase-2 enhances survival of chronic lymphocytic leukemia B cells.
16786043 This effect is statistically significant in lung cancer stage I, suggesting that COX-2 expression could be useful at early stages to distinguish those with a worse prognosis.
16984258 These studies suggest that SZ95 sebocytes express functional PAF-Rs and PAF-Rs are involved in regulating the expression of inflammatory mediators, including COX-2, PGE(2) and IL-8.
12920574 association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians
17418864 COX-2 expression in MCF10A breast epithelial cells confers a premalignant phenotype that includes enhanced genomic instability and altered cell-cycle regulation.
12532440 Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer.
12532441 Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. Expression of COX-2 mRNA in gastric carcinoma was significantly higher. Staging classification was significantly correlated with COX-2 over-expression.
15501771 expression in urethral epithelium upregulated by Neisseria gonorrhoeae PorB IB and upregulation dependent on NF-kappaB activation
12743126 biochemical pathway exists wherein fluid shear activates cyclooxygenase-2, via a c-Jun N-terminal kinase2/c-Jun-dependent pathway, which in turn elicits downstream prostaglandin EP2 and EP3a1 receptor mRNA synthesis
14747187 increased cyclooxygenase-2 expression in the endometriotic ovarian cyst wall was observed
15816645 cyclooxygenase-2 enzyme expression differs in radiosensitive versus radioresistant glioblastoma multiforme cell lines
12591723 Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.
12692419 Results suggest that expression of cyclooxygenase-2 is not correlated with clinicopathologic and biologic features of ampulla of Vater cancer.
14607721 Overexpression of COX-2 plays crucial role in carcinogenesis and development of extra-hepatic cholangiocarcinoma, indicating that COX-2 may serve as target for chemoprevention of extra-hepatic cholangiocarcinoma.
16681759 Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas
16699947 Forced COX-2 expression in gastric cancer cells did not inhibit apoptosis caused by NAG-1 expression.
16314473 COX-2 overexpression likely represents an additional mechanism of resistance to apoptosis in B chronic lymphoid leukemia.
17405913 H. pylori induces COX-2 expression, which is mediated by both activation and expression of PAR-2 in gastric epithelial cells
12821125 COX-2 has a role in generating prostaglandin e2 which increases VEGF secretion in human pancreatic cancer
14596920 sodium butyrate inhibits angiogenesis through down-regulation of COX-2 expression and prostaglandin (PG)E2 and PGI2 production
14749287 Glucose-induced induction of COX-2 in human islets suggest that this is one route through which hyperglycemia may contribute to beta-cell dysfunction
14989896 Cyclooxygenase-2 may be involved in the early stage of squamous carcinogenesis of the esophagus, and may be a target of prevention and treatment for esophageal squamous cell carcinoma.
15010822 Up-regulation of cyclooxygenase 2 correlates with vascular endothelial growth factor expression and tumor angiogenesis in HBV-associated hepatocellular carcinoma
15190260 COX1, but not COX2, is induced during ATRA-dependent maturation and appears to contribute to myeloid differentiation both in vitro and ex vivo, and COX-1 activity may potentiate the differentiation of human acute promyelocytic leukemia
15673847 Noncoplanar PCBs alter HL-60 cell function and COX-2 expression via an Ah-receptor-independent mechanism.
15804367 Atorvastatin down-regulates LPS-induced expression of the COX-2 and consequently inhibits production of PGE2 in cultured A549 cells.
11847219 Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression
12070598 Cox-2 could participate in the carcinogenic process of oral mucosa
16361272 a common PTGS2 variant increases bile duct cancer risk
14669280 Increase in Cox-2 expression is correlated with the loss of epithelial basement membrane in morphologically normal areas
12324457 mediation by NF-kappa B and Ku70 or Ku80
12679908 There is a correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma.
15146435 Basic calcium phosphate crystals may be an important amplifier of PGE(2) production through induction of the COX enzymes and the proinflammatory cytokine IL-1beta.
15375804 Review of COX-2 expression in squamous cell head and neck neoplasms.
15375805 Review of COX-2 in lung cancer treatment. COX-2 plays a role in lung cancer and may be a marker of prognosis.
15767259 The main signaling pathway for toxin A induction of human COX-2 involves ROS-mediated activation of p38 MAPK, MSK-1, CREB, and ATF-1
15867220 Findings suggest that COX-2 may be an effective therapeutic target in prostate cancer treatment.
16010419 Expression of COX2 is common in advanced urinary bladder cancer (BC) with poor prognostic characteristics, supporting efforts to initiate clinical trials on the efficacy of COX2 inhibitors in the adjuvant treatment of high-risk urinary BC.
16076963 MMP-1 expression by latanoprost requires prior up-regulation of COX-2
16331686 Findings disclose a cross-talk between the COX-2/PGE(2)/EP(1) and EGFR/c-Met signaling pathways that coordinately regulate human hepatocellular carcinoma cell invasion.
16357062 These results suggest that HRG might be a new member of the growth factor family involved in the COX-2-dependent ulcer repair process.
16399783 CCAAT/enhancer-binding protein beta (C/EBPbeta) DNA-binding sites are crucial for the function of the COX-2 gene promoter.
16632868 COX-2 and 15-PGDH are regulated reciprocally in A549 cells
17171651 Possible influence of the COX-2 C8473T SNP in Parkinson's disease, although it only seems to be of importance in men.
17404026 No association of COX-2 and inducible nitric oxide (NOS2) polymorphisms with cervical cancer is found in Korean women.
17404027 Vulvar cancer in elderly patients may be associated with inflammation, and thus with increased COX-2 expression.
12450219 COX-2 influences APP processing and promotes amyloidosis in the brain
12462194 inducible nitric oxide synthase-cyclooxygenase 2 interactions are involved in tumor cell angiogenesis and migration
12761889 regulation of expression by ATP
14555963 cell-cell contacts induce an actively programmed necrotic process that functionally involves COX-2, a known hallmark of inflammation and cancer
12701770 activation may be one of the distinct host degradative pathways in the pathogenesis of microbial-induced pulpal/periapical inflammation
14511332 COX-2 expression was dramatically increased in the spinal cord of patients with ALS.
16868662 These results implicate COX-2 in the angiogenesis and biological aggressiveness of diffuse astrocytomas.
11850206 Aromatase and COX-2 expression in human breast cancers.
11913955 Reduced prostate cancer growth after exposure to saw palmetto extract may relate to decreased expression of Cox-2
12162677 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia
11901151 overexpresssion in HER-2 positive breast cancer with involvement of AP-1 and PEA3
12664576 Activity is modulated in colorectal carcinoma cells.
12684668 hypermethylation of the CpG island in the cox-2 gene is a major mechanism that mediates transcriptional silencing in a subset of gastric cancers
12821538 COX-2 is induced in retinal astrocytes in human diabetic retinopathy, in the murine and rat model of ischemic proliferative retinopathy in vivo, and in hypoxic astrocytes in vitro. COX-2 but not COX-1 inhibitors prevented intravitreal neovascularization
14535998 H. pylori LPS is of low biological activity when compared with E. coli LPS in its ability to induce the expression of cyclooxygenase 2 and synthesis of prostaglandin E2
14645117 cross-linking of the RelA subunit of NF-kappa B but not C/EBP beta to the cox-2 promoter and flanking sequences after IL-1 treatment
14702352 COX-2-dependent prostanoids may play an important role in the regulation of hypoxia-induced Ang2 expression
14769824 COX2 and some prostanoids play a key role in IL-1beta-induced angiogenesis
14748725 Studies with the COX-2-selective inhibitor NS-398 confirmed the COX-2 dependency of the later increase in prostanoid production
15138244 We found that the -765G-->C polymorphism of the COX-2 gene is associated with a decreased risk of MI and stroke.
15246970 COX-2 plays a key role in VEGF production in gastric fibroblasts stimulated by IL-1 in vitro, and angiogenesis induced by the COX-2-VEGF pathway might be involved in gastric ulcer healing.
15100359 renovascular COX-2 expression was a constitutive feature encountered in human kidneys at all ages, whereas COX-2 was seen in macula densa only in fetal kidney.
15231484 Acid-induced activation of both ERK and p38 causes a significant increase in COX-2 promoter activity, and acid-activated ERK stabilizes COX-2 mRNA in Barrett's esophagus
15653566 high glucose, via PI3K/Akt signaling, induces NF-kappaB-related upregulation of COX-2, which in turn triggers the caspase-3 activity that facilitates vascular endothelium apoptosis
15789615 PGH synthase-2, CYP4F8, and PGE synthase-1 likely forms 19-hydroxy-PGE compounds in seminal vesicles and vas deferens
11911965 Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors
15896711 These results suggested that the combination of 5-FU and genistein exert a novel chemotherapeutic effect in colon cancers, and AMPK may be a regulatory molecule of COX-2 expression, further implying its involvement in cytotoxicity caused by genistein.
15921850 Elevated expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression
15963597 novel anti-inflammatory property of recombinant HBsAg which involves inhibition of COX-2.
12205039 Protein kinase C-epsilon mediates bradykinin-induced cyclooxygenase-2 expression in human airway smooth muscle cells
12698187 COX-2 upregulation contributes to oesophageal squamous carcinogenesis in head and neck cancer patients.
12885872 Data suggest that TIA-1 functions as a translational silencer of cyclooxygenase-2 (COX-2) expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.
14534699 COX-2 expression is down-regulated in cervical and vulvar tumor cells invading the regional lymph nodes with respect to primary tumors
15872218 Alternative polyadenylation of COX-2 may be an important post-transcriptional regulatory event.
15919917 data indicate that hepatitis C virus core suppresses IKK signalsome activity, which blunts COX-2 expression in macrophages
16044148 The loss of TNF-alpha-regulated COX-2 expression in ovarian neoplasms is associated closely with epithelial neoplastic morphological transformation.
16278387 Cyclooxygenase-2-dependent activation of STAT3 by interleukin-6 has a role in non-small cell lung cancer